Why is AbbVie Inc. stock down today?
August 27, 2026
AbbVie Inc.
ABBV · NYQ · USD
vs. prev. close $262.9
Last updated Aug 27, 2026 20:03
Intraday Chart — 5-min intervals
ABBV · less than a minute ago
AbbVie Inc. falls 1.81% as Exec Edge weighs on sentiment
The stock is at $258.15, a 1.81% move down versus the prior close of $262.90. Market context matters here: S&P 500: +0.7%, Nasdaq: +1.6%, Dow Jones: +0.2%, Shanghai: +1.7%, Hang Seng: +0.2%, leaving the overall tape under pressure.
The news backdrop is active, led by "Slate Medicines Starts Migraine Treatment Study" and "Is Merck Stock Reaching A Valuation Ceiling At 6x Sales?"; the headline mix is leaning negative.
Use this as a starting point for research, not as a trading recommendation.
Key Factors
Auto-generated analysis · Not financial advice
Slate Medicines Starts Migraine Treatment Study
Exec Edge·about 1 hour agoneutral
Is Merck Stock Reaching A Valuation Ceiling At 6x Sales?
Trefis·about 6 hours agoneutral
3 Rock Solid Dividend That Pay You Every Month
24/7 Wall St.·about 7 hours agoneutral
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
Zacks·about 8 hours agoneutralCan Cost Cuts And 2030 Targets Really Save Pfizer Stock?
Trefis·about 8 hours agonegative
When Inflation Is Sticky, 5 Dividend Aristocrats Are the Stocks to Own Now and Forever
24/7 Wall St.·about 10 hours agoneutral
AbbVie (ABBV) Filed For EU Crohn's Disease Label Expansion
Simply Wall St.·about 12 hours agoneutralAbbVie Seeks EU Approval for Subcutaneous Skyrizi Induction in Crohn's Disease
MT Newswires·about 15 hours agoneutral
S&P 500
+0.72%
Nasdaq
+1.57%
Dow Jones
+0.20%
Shanghai
+1.73%
Hang Seng
+0.21%
Nikkei 225
-0.20%
FTSE 100
-0.79%
Nifty 50
-1.00%
DAX
+0.31%
OMX Stockholm
-0.15%
Search another stock